WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on 1 APRIL 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • IFSIJ Measure of Journal Quality
  • Scientific Journal Impact Factor (SJIF)
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database

Abstract

HORMONE RECEPTOR AND HER-2 NEU STATUS IN BREAST CANCER PATIENTS ATTENDING RADIOTHERAPY OPD: AN INSTITUTIONAL EXPERIENCE

Dr. Swapan Kumar Mallick*, Dr. Arup Chakraborty, Dr. Arista Lahiri, Dr. Md Asifullah, Dr. Rajiv Lochan Jena and Dr. Madhumay Pal

ABSTRACT

Introduction: In breast cancer, hormonal status plays a very pivotal role in its etiology, prognosis and treatment in adjuvant as well as metastatic setting. This study explored hormonal profiles of the patients and metastasis in breast cancer. Materials & Methods: Breast cancer patient data were analysed retrospectively from institutional records during the study period from 1st January 2013 to 31st December 2017. The collected data was compiled into EpiInfo 7 software and subsequently analysis of data was done using SPSS software, version 16 and results are mentioned with the help of tables. Result and Discussion: Most of the breast cancer patients were of the age 40-60 years. Most of the patients had locally advanced carcinoma, 49.2%. Hormonal status was known for 82.2% of the patients. In our study ER positive, PR positive & Her-2 positive were 38.4%, 41.09% & 36.9% respectively of the whole sample and 46.67%, 50% & 45% respectively among the hormonal status known patients. Those who received hormonal therapy, were 31.5% amongst all the available records. Patients with HER2, ER & PR status positive (21.67%) and HER2 negative, but positive for ER & PR (16.67%) received hormonal therapy. While 23.33% patients did not receive hormonal therapy, being negative for HER2, ER & PR; it was also observed that 21.67% patients were not given any hormonal therapy, being ER & PR negative but HER2 positive. Conclusion: ER/PR positive was the most frequently observed hormonal profile in our population and this population is eligible for hormonal therapy.

[Full Text Article] [Download Certificate]